Kaplan–Meier analysis revealed that FOXD1, as compared to FOXD2, FOXD3 and FOXD4, upregulation more significantly (p = 0.008) predicts a poor overall survival rate in TCGA head and neck cancer patients (Figure 2A). The gene discussed is FOXD1; the disease is head and neck cancer.